Tailored surgery in the treatment of gastroesophageal cancer
© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature..
The surgical options and particularly perioperative treatment, have significantly advanced in the case of gastroesophageal cancer. This progress enables a 5-year survival rate of nearly 50% to be achieved through curative multimodal treatment concepts for locally advanced cancer. Therefore, in tumor boards and surgical case discussions the question increasingly arises regarding the type of treatment that provides optimal oncological and functional outcomes for individual patients with pre-existing diseases. It is therefore essential to carefully assess whether organ-preserving treatment might also be considered in the future or in what way minimally invasive or robotic surgery can offer advantages. Simultaneously, the boundaries of surgical and oncological treatment are currently being shifted in order to enable curative forms of treatment for patients with pre-existing conditions or those with oligometastatic diseases. With the integration of artificial intelligence into decision-making processes, new possibilities for information processing are increasingly becoming available to incorporate even more data into making decisions in the future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:95 |
|---|---|
| Enthalten in: |
Chirurgie (Heidelberg, Germany) - 95(2024), 4 vom: 27. März, Seite 261-267 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Maßgeschneiderte Chirurgie in der Behandlung gastroösophagealer Tumoren |
|---|
| Beteiligte Personen: |
Schmidt, Thomas [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Artificial intelligence |
|---|
| Anmerkungen: |
Date Completed 21.03.2024 Date Revised 21.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00104-024-02056-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369016246 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369016246 | ||
| 003 | DE-627 | ||
| 005 | 20240322000308.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00104-024-02056-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1339.xml |
| 035 | |a (DE-627)NLM369016246 | ||
| 035 | |a (NLM)38411664 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Schmidt, Thomas |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tailored surgery in the treatment of gastroesophageal cancer |
| 246 | 3 | 3 | |a Maßgeschneiderte Chirurgie in der Behandlung gastroösophagealer Tumoren |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.03.2024 | ||
| 500 | |a Date Revised 21.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature. | ||
| 520 | |a The surgical options and particularly perioperative treatment, have significantly advanced in the case of gastroesophageal cancer. This progress enables a 5-year survival rate of nearly 50% to be achieved through curative multimodal treatment concepts for locally advanced cancer. Therefore, in tumor boards and surgical case discussions the question increasingly arises regarding the type of treatment that provides optimal oncological and functional outcomes for individual patients with pre-existing diseases. It is therefore essential to carefully assess whether organ-preserving treatment might also be considered in the future or in what way minimally invasive or robotic surgery can offer advantages. Simultaneously, the boundaries of surgical and oncological treatment are currently being shifted in order to enable curative forms of treatment for patients with pre-existing conditions or those with oligometastatic diseases. With the integration of artificial intelligence into decision-making processes, new possibilities for information processing are increasingly becoming available to incorporate even more data into making decisions in the future | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Artificial intelligence | |
| 650 | 4 | |a Curative treatment | |
| 650 | 4 | |a Esophageal cancer | |
| 650 | 4 | |a Multimodal treatment | |
| 650 | 4 | |a Oligometastasis | |
| 700 | 1 | |a Fuchs, Hans F |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, Michael N |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Dolores T |e verfasserin |4 aut | |
| 700 | 1 | |a Lukomski, Leandra |e verfasserin |4 aut | |
| 700 | 1 | |a Scholz, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Bruns, Christiane J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chirurgie (Heidelberg, Germany) |d 2022 |g 95(2024), 4 vom: 27. März, Seite 261-267 |w (DE-627)NLM331472341 |x 2731-698X |7 nnns |
| 773 | 1 | 8 | |g volume:95 |g year:2024 |g number:4 |g day:27 |g month:03 |g pages:261-267 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00104-024-02056-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 95 |j 2024 |e 4 |b 27 |c 03 |h 261-267 | ||